Tremendous Growth Potential by Challenging Major OTT Service Providers

ME Newswire / Business Wire

RICHARDSON, Texas - Wednesday, March 5th 2014

Mavenir Systems (NYSE: MVNR), a leading provider of software-based networking solutions, today announced that it will provide Rich Communication Services (RCS) and WebRTC services to Mobile Telesystems (MOEX: MTSS), the leading provider of telecommunication services in Russia and the CIS.

Mavenir’s RCS solution, based on its Rich Messaging Server (RMS), enables advanced multimedia services such as instant messaging, file transfer, voice calling and video conferencing through a single application installed on the phone. Mavenir is also providing its WebRTC Gateway, based on the Unified Access Gateway (UAG), to enable delivery of RCS services to the web and introduce new unified communication services for the corporate segment.

"We are pleased to be working with a leading operator such as MTS to create innovat ... Read more »

ME Newswire / Business Wire

SAN DIEGO - Tuesday, March 4th 2014

Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced it has added Illumina NextSeq 500 systems to its force of NGS sequencers, enhancing the company’s established and highly efficient laboratory processes.

The NextSeq 500’s push-button operation provides a one-day turnaround time for an array of popular sequencing applications such as a single human genome, and up to 16 exomes, 20 transcriptomes, 48 gene expression samples, 20 non-invasive prenatal samples, and 96 targeted panels. Additionally, with the sequencer’s streamlined informatics, sequencing data can be run through a range of commercial pipelines.

"The addition of this advanced next-generation sequencing system provides our clinical laboratory with another powerful tool in the NGS space, adding to our current capabilities,” said David ... Read more »

ME Newswire / Businesswire

SEOUL, South Korea - Tuesday, March 4th 2014

Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully completed mesenchymal stem cell treatment for stroke patients.

Stroke refers to a disorder of partial or overall brain function that lasts for a considerable period of time, its causes, other than cerebrovascular disease, has not been found. Stroke is a general term for disease caused by cerebrovascular disorders, commonly refers to the cerebrovascular disease due to sudden circulatory disorder of brain blood vessels. This causes the loss of consciousness and paralysis of a body. Stroke occurs due to sudden neurological dysfunction regardless of causes, Symptoms include headache, vomiting, hemiplegia, or partial paralysis of body, sensory paralysis (or loss) of body part.

97.7 B & H Clinic intravenously injected stem cells to stroke pati ... Read more »